Palvella Therapeutics (PVLA) EPS (Basic) Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 139.68% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 25.99% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 41.58% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.28% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 58.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -2.92% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.92% |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | 56.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56.07% |
| Sep 30, 2025 | -99.36% |
| Jun 30, 2025 | -83.14% |
| Mar 31, 2025 | -119.47% |
| Dec 31, 2024 | 42.98% |
| Sep 30, 2024 | -154.15% |
| Jun 30, 2024 | -114.58% |
| Mar 31, 2024 | -180.20% |
| Dec 31, 2023 | 332.54% |
| Sep 30, 2023 | -222.24% |
| Jun 30, 2023 | 248.52% |
| Mar 31, 2023 | -486.88% |
| Sep 30, 2022 | -37.51% |
| Jun 30, 2022 | 16.45% |
| Mar 31, 2022 | 29.53% |
| Dec 31, 2021 | 14.77% |
| Sep 30, 2021 | -29.70% |
| Jun 30, 2021 | -305.10% |
| Mar 31, 2021 | 25.60% |
| Dec 31, 2020 | -51.02% |
| Sep 30, 2020 | -17.57% |
| Jun 30, 2020 | 26.86% |
| Mar 31, 2020 | 28.31% |
| Dec 31, 2019 | 27.89% |
| Sep 30, 2019 | 29.05% |
| Jun 30, 2019 | -19.68% |
| Mar 31, 2019 | -25.99% |
| Dec 31, 2018 | -44.22% |
| Sep 30, 2018 | -3.23% |
| Jun 30, 2018 | 68.47% |
| Mar 31, 2018 | -9.35% |
| Sep 30, 2017 | 2.00% |
| Jun 30, 2017 | 1.41% |
| Mar 31, 2017 | -39.49% |
| Dec 31, 2016 | -851.36% |
| Sep 30, 2016 | -429.21% |
| Jun 30, 2016 | -1,267.04% |